181 related articles for article (PubMed ID: 16782546)
1. Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression.
Fiszman G; Cattaneo V; de la Torre E; Español A; Colombo L; Sacerdote de Lustig E; Sales ME
Int Immunopharmacol; 2006 Aug; 6(8):1323-30. PubMed ID: 16782546
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic receptors are involved in LMM3 tumor cells proliferation and angiogenesis.
Rimmaudo LE; de la Torre E; Sacerdote de Lustig E; Sales ME
Biochem Biophys Res Commun; 2005 Sep; 334(4):1359-64. PubMed ID: 16040004
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines.
Español A; Eiján AM; Mazzoni E; Davel L; Jasnis MA; Sacerdote De Lustig E; Sales ME
Int J Mol Med; 2002 Jun; 9(6):651-7. PubMed ID: 12011984
[TBL] [Abstract][Full Text] [Related]
4. Role of non-neuronal cholinergic system in breast cancer progression.
Español AJ; de la Torre E; Fiszman GL; Sales ME
Life Sci; 2007 May; 80(24-25):2281-5. PubMed ID: 17276463
[TBL] [Abstract][Full Text] [Related]
5. Different muscarinc receptors are involved in the proliferation of murine mammary adenocarcinoma cell lines.
Español AJ; Sales ME
Int J Mol Med; 2004 Feb; 13(2):311-7. PubMed ID: 14719140
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice.
de la Torre E; Davel L; Jasnis MA; Gotoh T; de Lustig ES; Sales ME
Breast Cancer Res; 2005; 7(3):R345-52. PubMed ID: 15987429
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome.
Bacman S; Perez Leiros C; Sterin-Borda L; Hubscher O; Arana R; Borda E
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):151-6. PubMed ID: 9430556
[TBL] [Abstract][Full Text] [Related]
8. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against muscarinic receptors in breast cancer: their role in tumor angiogenesis.
Lombardi MG; Negroni MP; Pelegrina LT; Castro ME; Fiszman GL; Azar ME; Morgado CC; Sales ME
PLoS One; 2013; 8(2):e57572. PubMed ID: 23460876
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum.
Gonzalez-Gronow M; Cuchacovich M; Llanos C; Urzua C; Gawdi G; Pizzo SV
Cancer Res; 2006 Dec; 66(23):11424-31. PubMed ID: 17145889
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells.
Casanova M; Furlán C; Sterin-Borda L; Borda ES
Auton Autacoid Pharmacol; 2006 Jul; 26(3):293-301. PubMed ID: 16879495
[TBL] [Abstract][Full Text] [Related]
12. Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients.
Ganzinelli S; Borda T; Sterin-Borda L
Neuropharmacology; 2006 Mar; 50(3):362-71. PubMed ID: 16289249
[TBL] [Abstract][Full Text] [Related]
13. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
[TBL] [Abstract][Full Text] [Related]
14. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.
Fu LX; Magnusson Y; Bergh CH; Liljeqvist JA; Waagstein F; Hjalmarson A; Hoebeke J
J Clin Invest; 1993 May; 91(5):1964-8. PubMed ID: 7683693
[TBL] [Abstract][Full Text] [Related]
15. Constitutive muscarinic receptors are involved in the growth and differentiation of friend erythroleukemia cells.
Cellai C; Matucci R; Vannucchi AM; Paoletti F
J Cell Physiol; 1999 Mar; 178(3):333-40. PubMed ID: 9989779
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms lead to the angiogenic process induced by three adenocarcinoma cell lines.
Davel LE; Rimmaudo L; Español A; de la Torre E; Jasnis MA; Ribeiro ML; Gotoh T; de Lustig ES; Sales ME
Angiogenesis; 2004; 7(1):45-51. PubMed ID: 15302995
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
Cha S; Singson E; Cornelius J; Yagna JP; Knot HJ; Peck AB
J Rheumatol; 2006 Feb; 33(2):296-306. PubMed ID: 16465661
[TBL] [Abstract][Full Text] [Related]
19. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA
Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450
[TBL] [Abstract][Full Text] [Related]
20. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
